BioSpace News Archive

Izotropic Nominated for Best New Radiology Device Award

Auntminnie.com, a leading radiology news website, has recognized Izotropic’s IzoView Breast CT System in the Best New Radiology Device category.

September 9, 2021
·
3 min read
BioMidwest

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA qPCR Stool and Air-Dryable™ Direct RNA/DNA qPCR Stool Mixes.

September 9, 2021
·
3 min read
Emerging Peer-Reviewed Study Shows Reversal in Biological Hallmarks Responsible for Development of Alzheimer’s Disease

A new study, published today in peer-review medical journal Aging, marks the first time non-pharmaceutical clinical exploration proves efficacy in reversing the main activators of Alzheimer’s disease.

September 9, 2021
·
4 min read
Lone Star Bio

Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix

Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official launch of the FuseChoice™ Dermal Matrix line (“FuseChoice™ Derm”).

September 9, 2021
·
3 min read
Lone Star Bio

Cassava Sciences to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

Cassava Sciences, Inc. announced today that management will present at H.C. Wainwright’s 23rd Annual Global Investment Conference, a virtual event that takes place September 13-15, 2021.

September 9, 2021
·
1 min read
Genetown

Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent

Xenetic Biosciences, Inc. today announced the United States Patent and Trademark Office (USPTO) has issued Xenetic a Notice of Allowance for U.S. patent application number 16/983,491 entitled, “Articles and Methods Directed to Personalized Therapy of Cancer.”

September 9, 2021
·
6 min read
Business

Acorda Therapeutics Announces Corporate Restructuring, Management Changes

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a corporate restructuring to reduce costs and more closely align operating expenses with expected revenue.

September 9, 2021
·
5 min read
Drug Development

Dermavant Announces First Patient Dosed in ADORING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Atopic Dermatitis

Dermavant Sciences today announced that the first patient has been dosed in a Phase 3, double-blind, vehicle-controlled pivotal study of tapinarof for the treatment of atopic dermatitis (AD).

September 9, 2021
·
4 min read
FDA

Vonco Products Receives FDA 510(k) Clearance for Novel Closed-Loop Enteral Feeding Solution - EnteraLoc™ Flow

Vonco Products Receives FDA 510(k) Clearance for Novel Closed-Loop Enteral Feeding Solution - EnteraLoc™ Flow

September 9, 2021
·
3 min read
BioCapital

GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference

GemPharmatech (GemPharmatech Co., Ltd. “GPT”) presented its humanized mouse models to support T-Cell Bispecific antibody and COVID-19 preclinic development and co-hosted a panel discussion on bispecific antibodies at Biologics UK Oxford Global Conference, London, UK, Sept. 6-8, 2021

September 9, 2021
·
2 min read